✓ Medically reviewed by · Last reviewed: May 2026
Pharmacy Researcher · 8 years experience
Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.
Key takeaways
- ARBs and ACE inhibitors (losartan, telmisartan, olmesartan, ramipril, perindopril) are first-line for most adults with hypertension — strong outcome data, well-tolerated, organ-protective.
- Calcium channel blockers (amlodipine, nifedipine, diltiazem) are preferred first-line in older adults, Black patients, and those with isolated systolic hypertension.
- Thiazide-like diuretics (indapamide, hydrochlorothiazide) work synergistically with RAAS blockers — single-pill ARB+thiazide combinations are heavily evidence-supported.
- Beta-blockers are no longer first-line for uncomplicated hypertension but remain essential when hypertension co-exists with CHD, heart failure, or arrhythmia.
- Below: 10 best blood-pressure medications across all major classes, with mechanism, indication match, and decision shortcut.
Best Blood Pressure Medications in 2026: 10 Evidence-Backed Drugs Across All Classes
Modern hypertension treatment is class-driven and patient-driven. The 2024 ESC and 2024 NICE updates both recommend choosing first-line therapy based on age, ethnicity, and comorbidities — not “trying everything until something works.” This guide ranks the 10 most-used antihypertensive medications, organised by drug class so you can match treatment to clinical priority.
How modern BP treatment is structured
For most adults under 55, an ACE inhibitor or ARB is first-line. For adults over 55, or Black patients of any age, a calcium channel blocker is preferred. A thiazide-like diuretic gets added as second-line when monotherapy doesn’t reach target. Beta-blockers move to fourth-line for uncomplicated hypertension but stay first-line when there’s coronary artery disease, heart failure with reduced ejection fraction, or rhythm disorder.
Target BP for most adults is now <130/80 mmHg (SPRINT-influenced) but individualised — frail elderly accept <140/90 to avoid orthostatic falls; CKD with proteinuria pushes for tighter control. Combination therapy reaches target faster than monotherapy escalation; the 2024 ESC guidelines now recommend starting most patients on a two-drug single-pill combination directly.
1. Olmesar (Olmesartan 20/40 mg)
Class: Angiotensin II receptor blocker (ARB) · Manufacturer: Cipla · View product
Olmesartan is one of the most potent ARBs at standard dose — head-to-head studies show greater BP reduction than losartan or valsartan at equivalent milligrams. Long elimination half-life supports true 24-hour cover with once-daily dosing. Strongly recommended when 24-hour ambulatory BP shows nocturnal non-dipping or early-morning surge.
Side effects: dizziness, hyperkalaemia (rare), rare sprue-like enteropathy on long-term use. ARBs avoid the dry cough that complicates ACE inhibitors.
Pick for: uncomplicated hypertension, ACE-inhibitor cough, diabetic nephropathy, post-stroke secondary prevention.
2. Telmaheal (Telmisartan 20/40/80 mg)
Class: Angiotensin II receptor blocker (ARB) · Manufacturer: Healing Pharma · View product
Telmisartan has the longest half-life of any ARB (~24 h) and partial PPAR-γ activation, which gives a small metabolic benefit (improved insulin sensitivity, mild lipid effect). The ONTARGET trial established non-inferiority to ramipril for cardiovascular outcomes, with better tolerability. Often the ARB of choice when patients also have metabolic syndrome or pre-diabetes.
Pick for: hypertension with metabolic syndrome, when 24-hour cover is the priority.
3. Cozartan (Losartan 25/50/100 mg)
Class: ARB · Manufacturer: Lupin · View product
Losartan is the original ARB and the most-prescribed worldwide. The LIFE trial (vs atenolol) established stroke-reduction superiority in left-ventricular-hypertrophy patients. Active metabolite EXP-3174 carries most of the antihypertensive effect. Has weak uricosuric effect — preferred in patients with both hypertension and gout.
Pick for: hypertension with LVH, hypertension with gout/hyperuricaemia, cost-conscious ARB therapy.
4. Coversyl (Perindopril 2/4/8 mg)
Class: ACE inhibitor · Manufacturer: Servier · View product
Perindopril is the longest-acting ACE inhibitor in routine use. EUROPA, ASCOT, and ADVANCE trials established cardiovascular and renal mortality benefits across hypertension, stable CHD, and type-2 diabetes populations. Once-daily dosing is reliable. ACE inhibitors are preferred over ARBs in heart failure with reduced ejection fraction (stronger trial evidence).
Side effects: ACE-class dry cough (~10–15% of patients, switch to ARB if intolerable), rare angioedema, hyperkalaemia, first-dose hypotension.
Pick for: hypertension with CHD or HFrEF, diabetic nephropathy, when a long-acting ACE inhibitor is needed.
5. Rami Race (Ramipril 10 mg)
Class: ACE inhibitor · Manufacturer: Torrent · View product
Ramipril is the most widely studied ACE inhibitor — HOPE, MICRO-HOPE, and AIRE trials established mortality reductions in CHD, diabetes, and post-MI heart failure. The 10 mg target dose is what trial-derived benefit is built on. Many patients are under-titrated on 2.5–5 mg, so ensure proper escalation if BP is uncontrolled.
Pick for: post-MI secondary prevention, hypertension with established atherosclerotic disease, diabetic nephropathy.
6. Concor (Bisoprolol 5/10 mg)
Class: Cardioselective beta-blocker · Manufacturer: Merck · View product
Bisoprolol is the most cardioselective beta-blocker in routine use (β1:β2 selectivity ~75:1) — useful when you need beta-blockade without the bronchospasm risk of older agents. CIBIS-II established mortality reduction in HFrEF; ESC guidelines list bisoprolol as one of three first-line beta-blockers (with carvedilol and metoprolol succinate) for heart failure.
Side effects: bradycardia, fatigue early in titration, cold extremities, dose-dependent erectile dysfunction.
Pick for: hypertension with HFrEF, hypertension with rate-control need, hypertension with stable CHD.
7. Inderal (Propranolol 20/40 mg)
Class: Non-selective beta-blocker · Manufacturer: AstraZeneca · View product
Propranolol is the original beta-blocker — non-cardioselective, lipophilic, crosses the blood-brain barrier. Modern hypertension guidelines have downgraded propranolol for primary uncomplicated hypertension. Where it stays essential: essential tremor, migraine prophylaxis, performance anxiety, hyperthyroidism symptom control, portal hypertension, and primary prevention of variceal bleeding in cirrhotics.
Pick for: hypertension with co-existing essential tremor, migraine, anxiety, or thyrotoxicosis. Not ideal for asthma/COPD or peripheral vascular disease (use cardioselective like bisoprolol instead).
8. Amlode (Amlodipine 5/10 mg)
Class: Calcium channel blocker (dihydropyridine) · Manufacturer: Cipla · View product
Amlodipine is the most-prescribed CCB worldwide. Long half-life (~35 h) gives smooth 24-hour cover. ASCOT-BPLA and ACCOMPLISH trials established equivalent or superior outcomes vs older comparators, and the ACCOMPLISH amlodipine+benazepril arm beat the diuretic+benazepril arm on cardiovascular events. Particularly effective in older adults and Black patients (where RAAS-blocker monotherapy is less effective).
Side effects: ankle oedema (dose-dependent, ~10–25% at 10 mg), flushing, headache early in titration, gum hypertrophy on long-term high-dose use.
Pick for: first-line for adults >55 or Black patients, isolated systolic hypertension, hypertension with stable angina.
9. Lasix (Furosemide 40 mg)
Class: Loop diuretic · Manufacturer: Sanofi · View product
Furosemide is a powerful loop diuretic — not first-line for primary hypertension but essential when hypertension co-exists with heart failure, oedema, or significant CKD where thiazide diuretics lose effectiveness (eGFR <30). Short duration of action means dosing twice daily is preferred over once-daily for sustained effect.
Side effects: hypokalaemia, hyponatraemia, ototoxicity at high IV doses, gout flare from uric-acid retention, volume depletion in elderly.
Pick for: hypertension with heart failure or oedema, hypertension with eGFR <30, when thiazide-resistant volume overload requires loop diuretic.
10. Aldactone (Spironolactone 25/50/100 mg)
Class: Mineralocorticoid receptor antagonist (K-sparing diuretic) · Manufacturer: Pfizer · View product
Spironolactone is the fourth-line agent of choice for resistant hypertension — the PATHWAY-2 trial established superiority over alpha-blockers and beta-blockers in patients already on three antihypertensives. Acts at the distal nephron, blocking aldosterone-driven sodium retention. Also has primary indications in HFrEF (RALES), primary aldosteronism, and ascites.
Side effects: hyperkalaemia (check K+ at 1 week, 1 month, then quarterly when combined with ACE/ARB), gynaecomastia in men (~10% on 100 mg+), menstrual irregularity in women, fatigue.
Pick for: resistant hypertension on triple therapy, hypertension with primary aldosteronism, hypertension with HFrEF.
Comparison table: 10 BP medications at a glance
| Treatment | Class | Strength range | Best for | Key side effect |
|---|---|---|---|---|
| Olmesar | ARB | 20/40 mg | Uncomplicated HTN, ACE cough | Dizziness, hyperK |
| Telmaheal | ARB | 20/40/80 mg | HTN + metabolic syndrome | Dizziness |
| Cozartan | ARB | 25/50/100 mg | HTN + LVH or gout | Dizziness, hyperK |
| Coversyl | ACE inhibitor | 2/4/8 mg | HTN + CHD or HFrEF | Dry cough, hyperK |
| Rami Race | ACE inhibitor | 10 mg | Post-MI, diabetic nephropathy | Dry cough |
| Concor | β1-selective BB | 5/10 mg | HFrEF, rate-control | Bradycardia, fatigue |
| Inderal | Non-selective BB | 20/40 mg | HTN + tremor/migraine/thyroid | Bronchospasm, fatigue |
| Amlode | CCB (DHP) | 5/10 mg | Older adults, ISH, angina | Ankle oedema, flushing |
| Lasix | Loop diuretic | 40 mg | HTN + HF, low eGFR | HypoK, hypoNa, gout |
| Aldactone | MR antagonist | 25/50/100 mg | Resistant HTN, primary aldo | HyperK, gynaecomastia |
Decision shortcut
- Newly diagnosed, under 55, white European: start with an ARB (Olmesar / Telmaheal) or ACE inhibitor (Coversyl / Rami Race).
- Newly diagnosed, over 55 or Black African / Caribbean: start with amlodipine (Amlode) ± thiazide; add ARB if not at target.
- Hypertension with HFrEF: ACE inhibitor (Coversyl / Rami Race) + bisoprolol (Concor) + spironolactone (Aldactone). Triple therapy is the trial-validated mortality benefit.
- ACE inhibitor cough: switch to ARB. Same renin–angiotensin blockade; no bradykinin accumulation.
- Resistant hypertension on three drugs: add Aldactone (PATHWAY-2 evidence) before assuming primary aldosteronism — many “resistant” cases respond to the fourth-line MR antagonist.
- Hypertension with chronic kidney disease (eGFR <30): thiazides lose efficacy; switch the diuretic to a loop diuretic (Lasix). Keep ACE/ARB unless K+ is critical.
Frequently asked questions
What is the best blood pressure medication?
There’s no single “best” — class is chosen by age, ethnicity, and comorbidities. For most uncomplicated hypertension under 55, an ARB or ACE inhibitor is first-line. For older or Black patients, amlodipine is preferred. The 2024 ESC guidelines recommend starting most patients on a two-drug single-pill combination (typically ARB + amlodipine or ARB + thiazide) directly.
Are ARBs better than ACE inhibitors?
Roughly equivalent for uncomplicated hypertension. ACE inhibitors have stronger evidence in HFrEF and post-MI. ARBs are better tolerated (no cough, much lower angioedema risk). Switch from ACE to ARB if cough develops; never combine the two.
Should I take BP medication at night or in the morning?
The HYGIA trial suggested nocturnal dosing improves outcomes, but the larger TIME trial (2022) found no difference. Take it whenever you’ll remember. Consistency matters more than time of day. Exception: if you have orthostatic hypotension, morning dosing reduces fall risk.
Why are beta-blockers no longer first-line for hypertension?
Atenolol-based trials showed less stroke reduction than other classes for the same BP drop, and metabolic side effects (insulin resistance, lipid worsening) added long-term risk. Beta-blockers stay first-line when hypertension co-exists with CHD, HFrEF, or rhythm disorder — but not for uncomplicated hypertension.
Can I stop BP medication once my numbers normalise?
Almost never — for the vast majority, hypertension is a lifelong condition and stopping medication leads to BP rebound within weeks. Exceptions: weight-driven hypertension where 10–15 kg loss restores normotension; secondary hypertension where the underlying cause (e.g. primary aldosteronism, sleep apnoea, renal artery stenosis) has been corrected. Discuss with your clinician before stopping anything.
What’s the side-effect difference between amlodipine and an ARB?
Amlodipine causes ankle oedema (10–25% at 10 mg), flushing, and headache. ARBs cause dizziness early in titration and rare hyperkalaemia; otherwise very well tolerated. Both reduce events at equivalent BP drops; choose by side-effect tolerance and comorbidity match.
Are single-pill combinations better than two separate pills?
Yes — adherence is markedly higher (~20% absolute increase), BP control is reached faster, and trial outcomes (UMPIRE, FOCUS) confirm clinical benefit. Common evidence-based combinations: ARB+thiazide, ACE+amlodipine, ARB+amlodipine, ACE+amlodipine+thiazide (triple).
What about lifestyle changes?
Real and complementary — not substitute. Regular aerobic exercise drops systolic BP ~5–8 mmHg. DASH diet drops it ~6–11 mmHg. Sodium restriction (<1.5 g/day) drops it ~3–5 mmHg. Weight loss ~1 mmHg per kg lost. Combined lifestyle change can equal a single antihypertensive drug, but for most patients lifestyle + medication outperforms either alone.
Bottom line
Modern hypertension treatment is class-driven: ARB or ACE inhibitor for under-55s and most diabetics, amlodipine for over-55s and Black patients, thiazide added second-line, beta-blocker only when there’s coronary disease or HFrEF. Single-pill combinations are now first-line for most newly diagnosed patients. Resistance on three drugs? Add spironolactone before escalating further.
Related guides: Best hypertension medication for elderly · All heart & blood pressure products · Best cholesterol medications 2026
Written by
Sophie ChenPharmaceutical Content Researcher · 8 years experience
Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.